OOIR: Observatory of International Research

Papers

(The H4-Index of Cardiovascular Research is 46. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Matrix metalloproteinase-3 joins a growing list of proteases that regulate vascular calcification	1855
Is hypothermia more neuroprotective than avoiding fever after cardiac arrest?	253
Corrigendum to: CHARGE syndrome-associated CHD7 acts at ISL1-regulated enhancers to modulate second heart field gene expression	231
The backstage of the Russian–Ukrainian war: refugees in urgent need of cardiovascular management	199
Aircraft noise exposure induces pro-inflammatory vascular conditioning and amplifies vascular dysfunction and impairment of cardiac function after myocardial infarction	171
The proarrhythmogenic role of autonomics and emerging neuromodulation approaches to prevent sudden death in cardiac ion channelopathies	144
Marine omega-3 fatty acid supplementation and prevention of cardiovascular disease: update on the randomized trial evidence	127
Double-stranded DNA enhances platelet activation, thrombosis, and myocardial injury via cyclic GMP-AMP synthase	125
Circulating dimethylguanidino valeric acid, dietary factors, and risk of coronary heart disease	125
Hypoxic preconditioning effects change in hypertrophied or insulin resistant rat hearts	125
Increased oxidative stress alters coronary microvascular tone in exercising swine with multiple comorbidities	117
Oral Presentation No. 019 Bi-directional cross talk between coagulation, fibrinolysis and inflammatory pathways in patients with ST-segment elevation myocardial infarction	110
Early biomarkers of disease in hypertrophic cardiomyopathy: does telomere length matter?	106
Blockers of Hyperpolarization-activated Cyclic Nucleotide-gated channels exhibit antimuscarinic properties in human atrial cardiomyocytes	101
The role of uremic toxin indoxyl sulfate in the pathophysiology of aortic valve stenosis	101
Inhibition of novel lipoprotein(a) receptor major facilitator superfamily domain containing 5 (MFSD5) reduces development of aortic valve calcification	98
Inflammation-induced arterial dysfunction in atherosclerosis; the modulating action of mesenchymal stem cell-derived extracellular vesicles	97
Poster No. 106 Can we optimize d-dimer cut off value to predict pulmonary embolism in covid-19 patients?	90
Exogenous Growth Differentiation Factor 15 (GDF15) exerts direct cardioprotective properties towards myocardial ischemia reperfusion injury	90
Clinical Case 18—Management of patient with cancer and confirmed systemic thrombosis and rectal bleeding	90
Investigating the cardiotoxicity of particulate matter air pollution using a mouse model	89
Telomerase and myocardin co-expressing mesenchymal cells increase survival and induce cardiac and vascular markers in cardiac stromal cells undergoing simulated ischemia/reperfusion	88
Timing of capillary enlargement after adenoviral VEGF gene transfer does not support post-ischemic skeletal muscle recovery in hyperlipidemic mice	86
FABP4 as potential indicator for GDM-induced fetal endothelial dysfunction	83
Elderberry extract inhibits tumour necrosis factor induced monocyte adhesion to endothelial cells via modulation of the NF-κB pathway	72

Micromanaging atherosclerosis: myeloid cell-specific microRNA-26b attenuates atherosclerosis development	72
In vivo calcium and voltage mapping of the zebrafish heart	71
Novel ex-vivo calcification model for human aortic valves reveals patient-specific effect of compound	70
Clinical Case 08—A challenging clinical case: acute limb ischemia as a presentation of a left ventricular thrombus in a patient with heart failure with reduced ejection fraction	67
The mechanistic role of connexin 43 in maturation of hiPSC cardiomyocytes	61
Propafenone as potential AgoKir: exploration of long-term effects and mechanisms of propafenone on Kir2.1 channel	58
Impaired autophagy mechanisms associated with phospholamban-R14del disease	58
Should we resurrect acetazolamide as a diuretic for congestion due to heart failure?	58
Annexin A1: a promising target for preventing aortic dissections	57
Ecto-CD38-NADase inhibition modulates cardiac metabolism and protects mice against doxorubicin-induced cardiotoxicity	57
Decreasing microtubule detyrosination modulates Nav1.5 subcellular distribution and restores sodium current in mdx cardiomyocytes	54
PRDM16, a new kid on the block in cardiovascular health and disease	54
SARS-CoV-2 induced vascular endothelial dysfunction: direct or indirect effects?	53
Cardioprotection in cardio-oncology: a case for concern?	51
Mapping the developing human cardiac endothelium at single-cell resolution identifies MECOM as a regulator of arteriovenous gene expression	50
Corrigendum to: Transient stabilization of human cardiovascular progenitor cells from human pluripotent stem cells in vitro reflects stage-specific heart development in vivo	49
Accelerating developments in heart failure	49
TNF-α protects from exacerbated myocarditis and cardiac death by suppressing expansion of activated heart-reactive CD4+ T cells	49
Rapamycin reduces atherosclerotic plaque inflammation in aged mice	49
Acidic environments trigger intracellular H+-sensing FAK proteins to re-balance sarcolemmal acid–base transporters and auto-regulate cardiomyocyte pH	48
GLUT-1/PKM2 loop dysregulation in patients with non-ST-segment elevation myocardial infarction promotes metainflammation	47
Conquering cholesterol: a report from the front lines	46
The effect of probiotic and synbiotic supplementation on lipid parameters among patients with cardiometabolic risk factors: a systematic review and meta-analysis of clinical trials	46